A retrospective analysis of more than 400,000 U.S. births over nearly 6 years shows that delivery of triplets or more costs 20 times as much as a singleton. Published in The American Journal of Obstetrics and Gynecology, the report may be the first to look at medical expenses for both maternal and infant care associated with IVF-assisted pregnancy.
A retrospective analysis of more than 400,000 U.S. births over nearly 6 years shows that delivery of triplets or more costs 20 times as much as a singleton. Published in The American Journal of Obstetrics and Gynecology, the report may be the first to look at medical expenses for both maternal and infant care associated with IVF-assisted pregnancy.
The analysis, based on data from the Truven Health MarketScan Commercial Claims and Encounters, included 437,924 deliveries of live-born infants to women aged 19 to 45 from January 2005 to September 2010. Costs included payments made by insurers and patients. Expenses from 27 weeks before delivery to 1 month after delivery were included for mothers, and for infants, included all expenses until their first birthday. A generalized linear model was used to estimate adjusted cost.
Of the deliveries, 97.02% were singletons, 2.85% were twins, and 0.13% were triplets or higher. For singletons, the adjusted total all-cause health care cost was $21,458 (95% CI, $21,302-$21,614) per delivery, versus $104,831 (95% CI, $103,402-$106,280) for twins and $407,199 (95% CI, $384,984-$430,695) for triplets or more.
Incidence of systemic and localized comorbidity was significantly higher in women with multiple pregnancies than with singletons (P<.0001) and twins and triplets were more likely than singletons to have stayed in a neonatal intensive care unit (P<.0001).
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Cesarean deliveries linked to reduced fecundability and increased infertility risk
June 27th 2024A recent study found that women with multiple children and a history of cesarean deliveries face lower fecundability and higher infertility risks compared to those with vaginal deliveries.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More